Patents by Inventor Andrea Bourdelais

Andrea Bourdelais has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ladder-Frame Polyether Conjugates
    Publication number: 20160128321
    Abstract: Disclosed are compounds that are conjugates of ladder frame polyether compounds and biologically active compounds or research compounds, pharmaceutical formulations comprising the conjugates, and methods of transporting the conjugates across biological membranes.
    Type: Application
    Filed: January 13, 2016
    Publication date: May 12, 2016
    Inventors: Andrea Bourdelais, Daniel G. Baden, Alan Goodman, Steven Fontana
  • Ladder-Frame Polyether Conjugates
    Publication number: 20120077778
    Abstract: Disclosed are compounds that are conjugates of ladder frame polyether compounds and biologically active compounds or research compounds, pharmaceutical formulations comprising the conjugates, and methods of transporting the conjugates across biological membranes.
    Type: Application
    Filed: September 29, 2010
    Publication date: March 29, 2012
    Inventors: Andrea Bourdelais, Daniel Baden, Allan Goodman, Steven Fontana
  • Fused Pentacyclic Polyethers
    Publication number: 20070179116
    Abstract: Disclosed are polycyclic polyether compounds of formula I and pharmaceutical compositions comprising such compounds. wherein R, OR1, and R2 are as defined herein. Also disclosed are methods of regulating mucus clearance in a cell, and methods of treating decreased mucus clearance or mucociliary dysfunction.
    Type: Application
    Filed: April 10, 2007
    Publication date: August 2, 2007
    Inventors: Daniel Baden, William Abraham, Andrea Bourdelais
  • Fused pentacyclic polyethers
    Publication number: 20050148539
    Abstract: Disclosed are polycyclic polyether compounds of formula I and pharmaceutical compositions comprising such compounds. wherein R, OR1, and R2 are as defined herein. Also disclosed are methods of regulating mucus clearance in a cell, and methods of treating decreased mucus clearance or mucociliary dysfunction.
    Type: Application
    Filed: September 20, 2004
    Publication date: July 7, 2005
    Applicant: University of North Carolina
    Inventors: Daniel G. Baden, William Abraham, Andrea Bourdelais
  • Polyether brevetoxin derivatives as a treatment for cystic fibrosis, mucociliary dysfunction, and pulmonary diseases
    Publication number: 20050124686
    Abstract: Disclosed are compounds that are derivatives of brevetoxin, or PbTx, pharmaceutical formulations comprising the compounds, and methods of regulating mucus transport in a cell, treating mucociliary dysfunction and diseases related to decreased mucus transport, wherein the compounds are of the Formula (I), and Formula (III): wherein R, R1, R2, R3, A, n, and Y are as defined herein for each compound.
    Type: Application
    Filed: September 20, 2004
    Publication date: June 9, 2005
    Applicant: University of North Carolina
    Inventors: Daniel Baden, William Abraham, Andrea Bourdelais